Audio Journal of Cardiovascular Medicine: September 8th 2006

Audio Journal of Cardiovascular Medicine: September 8th 2006

0:00

Christoph Kaiser John Cleland BASKET Study Shows Bare Metal Stents Can Be Better REFERENCE: 4825 “Clinical Trial Update I” Session Christoph Kaiser, University of Basel Bare metal stents m

Christoph Kaiser

Christoph Kaiser

John Cleland

John Cleland

BASKET Study Shows Bare Metal Stents Can Be Better

REFERENCE: 4825 “Clinical Trial Update I” SessionChristoph Kaiser, University of BaselBare metal stents may be just as effective, and in some lesions even more effective, than drug eluting stents, according to the findings of the BASKET trial from the University of Basel in which patients receiving drug eluting stents were compared with others having bare metal stents.Christoph Kaisertold a “Clinical Trial Update” session in Barcelona, that it is important to define sub-groups of patients who will do better on bare metal stents rather than simply giving drug eluting stents to all. He discussed the study with Peter Goodwin.

Perindopril Benefits Older Patients with Diastolic Heart Failure

REFERENCE: Abstract 984John Cleland, University of HullA new way of relieving symptoms and reducing morbidity in older patients with diastolic heart failure was announced at the cardiology congress in Barcelona.John Clelandfrom Hull University in the UK presented his results on the PEP-CHF (Perindopril in Elderly People with Chronic Heart Failure) study looking at the use of the ACE-inhibitor perindopril in comparison with placebo. He explained to Sarah Maxwell that although the investigators found an unexpectedly low rate of mortality and morbidity in both arms of the study, the ACE inhibitor brought worthwhile benefits.

Related Episodes

TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent?

TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent?

Gregg Stone REFERENCE: Abstract 2357, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida GREGG STONE, Columbia University, New York New light has been thrown on the u

Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI

Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI

Laura Mauri Raymond Gibbons REFERENCE: Late Breaking Special Session, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida LAURA MAURI, Brigham and Woman’s Hospit

Patients with High Restenosis Risk Benefit More from Drug Eluting Stents

Patients with High Restenosis Risk Benefit More from Drug Eluting Stents

Raul Moreno REFERENCE: Abstract 3103, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria RAUL MORENO, University Hospital La Paz, Madrid Results from a large meta analysis s